|
Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. PubMed PMID: 23572113.
AÑO: 2013; IF: 5.76
|
23572113
|
Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol. 2013 Apr 15;111(8):1159-64. doi: 10.1016/j.amjcard.2012.12.045. PubMed PMID: 23337836.
AÑO: 2013; IF: 3.425
|
|
Anton AI, Cerezo-Manchado JJ, Padilla J, Perez-Andreu V, Corral J, Vicente V, Roldan V, Gonzalez-Conejero R. Novel associations of VKORC1 variants with higher acenocoumarol requirements. PLoS One. 2013 May 17;8(5):e64469. doi: 10.1371/journal.pone.0064469. PubMed PMID: 23691226; PubMed Central PMCID: PMC3656883.
AÑO: 2013; IF: 3.534
|
|
Navarro S, Medina P, Bonet E, Corral J, Martínez-Sales V, Martos L, Rivera M, Roselló-Lletí E, Alberca I, Roldán V, Mira Y, Ferrando F, Estellés A, Vicente V, Bertina RM, España F. Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1435-40. doi: 10.1161/ATVBAHA.113.301360. PubMed PMID: 23520161.
AÑO: 2013; IF: 5.533
|
|
Cerezo-Manchado JJ, Rosafalco M, Antón AI, Pérez-Andreu V, Garcia-Barberá N, Martinez AB, Corral J, Vicente V, González-Conejero R, Roldán V. Creating a genotype-based dosing algorithm for acenocoumarol steady dose. Thromb Haemost. 2013 Jan;109(1):146-53. doi: 10.1160/TH12-08-0631. PubMed PMID: 23196355.
AÑO: 2013; IF: 5.76
|